Diving Deeper Into the Relationship Between Inflammation and Depression in Lung Cancer
In this video, Dr. McFarland of Memorial Sloan-Kettering Cancer Center spoke with Cancer Network at ASCO 2019 about depression in lung cancer and dopamine as potential therapy.
Cancer Network spoke with Daniel C. McFarland, DO, medical oncologist at Memorial Sloan-Kettering Cancer Center, at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting about the relationship between inflammation and depression in lung cancer patients and the potential efficacy of dopamine in treating depression.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Recent Videos
Related Content
